Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17502459 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Coenzyme Q10 Nanodispersion (Nanoquinone);   Drug: Placebo

Indicates status has not been verified in more than two years